Biofidelity Ltd. announced that it has received $24 million in a round of funding on April 3, 2024. The transaction included participation from returning investors, Agilent Technologies, Inc., Octopus Ventures Ltd., Blue Yard Capital, and Longwall Venture Partners LLP. The company has raised $60 million funding till date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
150.7 USD | +0.07% | -2.31% | +8.37% |
May. 23 | Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors | CI |
May. 23 | Agilent Technologies, Inc. Unveils the 8850 Gas Chromatograph | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.37% | 44.15B | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+3.27% | 36.45B | |
+23.97% | 31.33B |
- Stock Market
- Equities
- A Stock
- News Agilent Technologies, Inc.
- Biofidelity Ltd. announced that it has received $24 million in funding from Agilent Technologies, Inc., Octopus Ventures Ltd., Blue Yard Capital, Longwall Venture Partners LLP